The Dutch EPS Registry: Increasing the knowledge of encapsulating peritoneal sclerosis

Netherlands Journal of Medicine

Volumn 67, Issue 8, 2009, Pages 359-362

  Korte, M R ^a   Boeschoten, E W ^b   Betjes, M G H ^c  

^a ALBERT SCHWEITZER HOSPITAL   (Netherlands)

^b Hans Mak Institute   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

EPS; Incidence; Registry; Risk factors

Indexed keywords

DIALYSIS; ENCAPSULATING PERITONEAL SCLEROSIS; HUMAN; INCIDENCE; INTESTINE OBSTRUCTION; KIDNEY TRANSPLANTATION; PRACTICE GUIDELINE; REGISTER; REVIEW; SCLEROSING PERITONITIS; TREATMENT DURATION; VISCERA;

ACCESS TO INFORMATION; DATA COLLECTION; EVIDENCE-BASED MEDICINE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INCIDENCE; MULTIVARIATE ANALYSIS; NETHERLANDS; PERITONEAL DIALYSIS; PERITONEAL DISEASES; PERITONEUM; REGISTRIES; RISK FACTORS; SCLEROSIS;

EID: 70349655639     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Chin AI, Yeun JY. Encapsulating peritoneal sclerosis: an unpredictable and devastating complication of peritoneal dialysis. Am J Kidney Dis. 2006;47:697-712.
2. Rigby RJ, Hawley CM. Sclerosing peritonitis: the experience in Australia. Nephrol Dial Transplant. 1998;13:154-159
3. Kawanishi H, Kawaguchi Y, Fukui H, et al. Encapsulating peritoneal sclerosis in Japan: a prospective, controlled, multicenter study. Am J Kidney Dis. 2004;44:729-737 (Pubitemid 39237618)
4. Summers AM, Clancy MJ, Syed F, et al. Single-center experience of encapsulating peritoneal sclerosis in patients on peritoneal dialysis for end-stage renal failure. Kidney Int. 2005;68:2381-2388 (Pubitemid 43117819)
5. Korte MR, Yo M, Betjes MG, et al. Increasing incidence of severe encapsulating peritoneal sclerosis after kidney transplantation. Nephrol Dial Transplant. 2007;22:2412-2414 (Pubitemid 47244739)
6. Fieren MW, Betjes MG, Korte MR, Boer WH. Posttransplant encapsulating peritoneal sclerosis: a worrying new trend? Perit Dial Int. 2007;27:619-624
7. Burkart J, Piraino B, Kaldas H, et al. Why is the evidence favoring haemodialysis over peritoneal dialysis misleading? Semin Dial. 2007;20:200-202
8. Krediet RT. How to preserve residual renal function in patients with chronic kidney disease and on dialysis? Nephrol Dial Transplant. 2006;21 Suppl 2:ii42-6.
9. Coester AKR, Boeschoten E. Nephrologists' Perception of PD in the Netherlands. Perit Dial Int. 2008;28, S4 (abstract 286).S88.
10. Kawaguchi Y, Kawanishi H, Mujais S, Topley N, Oreopoulos DG. Encapsulating peritoneal sclerosis: definition, etiology, diagnosis, and treatment. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis. Perit Dial Int. 2000;20(Suppl 4):S43-55.
11. Tarzi RM, Lim A, Moser S, et al. Assessing the validity of an abdominal CT scoring system in the diagnosis of encapsulating peritoneal sclerosis. Clin J Am Soc Nephrol. 2008;3:1702-1710
12. Williams JD, Craig KJ, Topley N, Williams GT. Peritoneal dialysis: changes to the structure of the peritoneal membrane and potential for biocompatible solutions. Kidney Int Suppl. 2003;63(Suppl 84):S158-61. (Pubitemid 36513400)
13. Mateijsen MA, van der Wal AC, Hendriks PM, et al. Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis. Perit Dial Int. 1999;19:517-525
14. Selgas R, Bajo A, Jimenez-Heffernan JA, et al. Epithelial-to-mesenchymal transition of the mesothelial cell-its role in the response of the peritoneum to dialysis. Nephrol Dial Transplant. 2006;21(Suppl 2):ii2-7. (Pubitemid 44018935)
15. Margetts PJ, Bonniaud P, Liu L, et al. Transient overexpression of TGF-{beta}1 induces epithelial mesenchymal transition in the rodent peritoneum. J Am Soc Nephrol. 2005;16:425-436 (Pubitemid 41725138)
16. Io H, Hamada C, Ro Y, Ito Y, Hirahara I, Tomino Y. Morphologic changes of peritoneum and expression of VEGF in encapsulated peritoneal sclerosis rat models. Kidney Int. 2004;65:1927-1936 (Pubitemid 38591045)
17. Garosi G, Di Paolo N, Sacchi G, Gaggiotti E. Sclerosing peritonitis: a nosological entity. Perit Dial Int. 2005;25(Suppl 3):S110-2.
18. Saito A. Peritoneal dialysis in Japan: the issue of encapsulating peritoneal sclerosis and future challenges. Perit Dial Int. 2005;25(Suppl 4):S77-82. (Pubitemid 41600363)
19. Yamamoto R, Otsuka Y, Nakayama M, et al. Risk factors for encapsulating peritoneal sclerosis in patients who have experienced peritoneal dialysis treatment. Clin Exp Nephrol. 2005;9:148-152 (Pubitemid 40875105)
20. Hendriks PM, Ho-dac-Pannekeet MM, van Gulik TM, et al. Peritoneal sclerosis in chronic peritoneal dialysis patients: analysis of clinical presentation, risk factors, and peritoneal transport kinetics. Perit Dial Int. 1997;17:136-143
21. de Freitas D, Jordaan A, Williams R, et al. Nutritional management of patients undergoing surgery following diagnosis with encapsulating peritoneal sclerosis. Perit Dial Int. 2008;28:271-276 (Pubitemid 352003042)
22. Junor BJ, McMillan MA. Immunosuppression in sclerosing peritonitis. Adv Perit Dial. 1993;9:187-189
23. Eltoum MA, Wright S, Atchley J, Mason JC. Four consecutive cases of peritoneal dialysis-related encapsulating peritoneal sclerosis treated successfully with tamoxifen. Perit Dial Int. 2006;26:203-206 (Pubitemid 44336172)
24. Balasubramaniam G, Brown EA, Davenport A, et al. The Pan-Thames EPS study: treatment and outcomes of encapsulating peritoneal sclerosis. Nephrol Dial Transplant. 2009; Feb 11 (Epub ahead of print).
25. Lafrance JP, Letourneau I, Ouimet D, et al. Successful treatment of encapsulating peritoneal sclerosis with immunosuppressive therapy. Am J Kidney Dis. 2008; 51:e7-10.
26. Kawanishi H, Ide K, Yamashita M, et al. Surgical techniques for prevention of recurrence after total enterolysis in encapsulating peritoneal sclerosis. Adv Perit Dial. 2008; 24:51-55